Funder
Cystic Fibrosis Foundation
Reference29 articles.
1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry: 2022 Annual Data Report Bethesda, MD: Cystic Fibrosis Foundation; 2023.
2. The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation;Caverly;Clin Chest Med,2022
3. Update on Clinical Outcomes of Highly Effective Modulator Therapy;Gifford;Clin Chest Med,2022
4. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials;Mayer-Hamblett;Lancet Respir Med,2023
5. The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: the SIMPLIFY-MCC Study;Donaldson;J Cyst Fibros,2024